X-linked severe combined immunodeficiency - PDFSEARCH.IO - Document Search Engine

X-linked severe combined immunodeficiency
Results: 55

#	Item
21	Office of Biotechnology Activities National Institutes of Health U.S. Department of Health and Human Services Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-14 15:28:50 Biotechnology Rare diseases Bioethics Severe combined immunodeficiency Viral vector Gene therapy X-linked severe combined immunodeficiency Retrovirus Common gamma chain Biology Gene delivery Molecular biology
22	Severe Combined Immunodeficiencies Unknown (7% Reticular Dysgenesi (<1%) Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-14 15:30:32 Biotechnology Rare diseases Molecular biology Bioethics Gene therapy Health and Social Care Survey Adenosine deaminase deficiency X-linked severe combined immunodeficiency Biology Health Medicine
23	On February 10, 2003, after extensive discussion, the NIH Recombinant DNA Advisory Committee (RAC) reached the following concl Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-14 15:29:09 Biotechnology Emerging technologies Medical research Gene therapy Severe combined immunodeficiency Viral vector X-linked severe combined immunodeficiency Retrovirus Stem cell Biology Gene delivery Molecular biology
24	CPSP HIGHLIGHTS Severe combined immunodeficiency: A tale of two brothers male infant presented at five months of age with eventually fatal respiratory syncytial virus infection, and a history of chronic oral candidiasis Add to Reading List Source URL: www.cpsp.cps.ca Language: English - Date: 2012-10-22 14:27:43 Rare diseases Severe combined immunodeficiency X-linked severe combined immunodeficiency Gene therapy Immunodeficiency Adenosine deaminase deficiency Hematopoietic stem cell transplantation Scid Bacillus Calmette-Guérin Medicine Health Biology
25	Informed Consents for Clinical T i l Using Trials U i Integrating I i Vectors Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-09 12:09:34 Viral vector Retrovirus Severe combined immunodeficiency X-linked severe combined immunodeficiency Vector Virus Vectors in Gene Therapy Biology Gene delivery Molecular biology
26	Evolution of Gene Therapy • Gene therapy research is experimental - at a very early, immature stage • Present methods and tools are nascent and still unrefined and also carry risk, but, • The X-SCID gene transfer s Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-14 15:29:51 Molecular biology Applied genetics Medical genetics Gene therapy Viral vector Retrovirus Leukemia Severe combined immunodeficiency X-linked severe combined immunodeficiency Biology Gene delivery Biotechnology
27	Severe Combined Immunodeficiencies Unknown (7% CD3G(<1% ADA Deficiency (16%) Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-14 15:25:23 Biotechnology Rare diseases Molecular biology Bioethics Gene therapy Health and Social Care Survey Adenosine deaminase deficiency Lymphoproliferative disorders X-linked severe combined immunodeficiency Biology Health Medicine
28	On February 10, 2003, after extensive discussion, the NIH Recombinant DNA Advisory Committee (RAC) reached the following concl Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2013-12-16 09:39:46 Biotechnology Emerging technologies Medical research Gene therapy Severe combined immunodeficiency Viral vector X-linked severe combined immunodeficiency Retrovirus Stem cell Biology Gene delivery Molecular biology
29	RETROVIRAL GENE TRANSDUCTION OF HUMAN CD34+ CELLS IN CLOSED CULTURE GAS PERMEABLE CONTAINERS Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-14 15:25:11 Gene delivery Transplantation medicine Rare diseases Janus kinase 3 Severe combined immunodeficiency Emerging technologies Medical research X-linked severe combined immunodeficiency Gene therapy Medicine Biology Health
30	Severe Combined Immunodeficiencies Unknown (7% Reticular Dysgenesi (<1%) Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-09 11:54:01 Biotechnology Rare diseases Molecular biology Bioethics Gene therapy Health and Social Care Survey Adenosine deaminase deficiency X-linked severe combined immunodeficiency Biology Health Medicine

UPDATE